These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27917635)

  • 21. Raynaud's phenomenon: pathogenesis and management.
    Bakst R; Merola JF; Franks AG; Sanchez M
    J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of thoracic outlet syndrome on the epidemiology and clinical presentation of apparently primary Raynaud's phenomenon. A prospective study in 570 patients.
    Pistorius MA; Planchon B
    Int Angiol; 1995 Mar; 14(1):60-4. PubMed ID: 7658106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Raynaud's phenomenon in common rheumatic diseases.
    Lambova SN; Kuzmanova SI
    Folia Med (Plovdiv); 2006; 48(3-4):22-8. PubMed ID: 17668693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raynaud's phenomenon.
    Hughes M; Herrick AL
    Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):112-32. PubMed ID: 27421220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of patients with severe secondary Raynaud's phenomenon with the endothelin receptor antagonist bosentan.
    Selenko-Gebauer N; Duschek N; Minimair G; Stingl G; Karlhofer F
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii45-8. PubMed ID: 16987835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ischemic ulcers of the toes secondary to Raynaud's phenomenon in a child successfully treated with botulinum toxin.
    Quintana Castanedo L; Feito Rodríguez M; Maseda Pedrero R; Chiloeches Fernández C; de Lucas Laguna R
    Pediatr Dermatol; 2020 Jul; 37(4):681-683. PubMed ID: 32212180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nailfold capillaroscopy in the screening and diagnosis of Raynaud's phenomenon.
    Mannarino E; Pasqualini L; Fedeli F; Scricciolo V; Innocente S
    Angiology; 1994 Jan; 45(1):37-42. PubMed ID: 8285382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Raynaud's phenomenon : Practical management].
    Drerup C; Maier A; Ehrchen J
    Z Rheumatol; 2019 Dec; 78(10):967-978. PubMed ID: 31712897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnosis and treatment of Raynaud's phenomenon: a practical approach.
    Pope JE
    Drugs; 2007; 67(4):517-25. PubMed ID: 17352512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of Raynaud's phenomenon with alpha-lytic agents].
    Clément DL
    Rev Med Liege; 1980 Oct; 35(19):650-2. PubMed ID: 6109369
    [No Abstract]   [Full Text] [Related]  

  • 31. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnosis and treatment of Raynaud's phenomenon.
    Porter JM; Snider RL; Bardana EJ; Rösch J; Eidemiller LR
    Surgery; 1975 Jan; 77(1):11-23. PubMed ID: 1078555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The usefulness of capillaroscopy for the evaluation of pulsed magnetic field therapy in patients with primary and secondary Raynaud's phenomenon].
    Kuryliszyn-Moskal A; Kita J; Dakowicz A; Klimiuk PA
    Ann Acad Med Stetin; 2011; 57(3):17-22; discussion 22. PubMed ID: 23383543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Raynaud's phenomenon: effects of terazosin].
    Paterna S; Pinto A; Arrostuto A; Cannavò MG; Di Pasquale P; Cottone C; Licata G
    Minerva Cardioangiol; 1997 May; 45(5):215-21. PubMed ID: 9273472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Raynaud's phenomenon - first sign of malignancy: case report].
    Sutić A; Gračanin G; Morović-Vergles J
    Acta Med Croatica; 2014 Jun; 68(3):295-8. PubMed ID: 26016221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Minimal work-up for Raynaud syndrome: a consensus report. Microcirculation working group of the Société française de médecine vasculaire].
    Pistorius MA; Carpentier PH;
    Ann Dermatol Venereol; 2013; 140(8-9):549-54. PubMed ID: 24034643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon.
    Schuhfried O; Vacariu G; Lang T; Korpan M; Kiener HP; Fialka-Moser V
    Arch Phys Med Rehabil; 2000 Apr; 81(4):495-9. PubMed ID: 10768542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Raynaud's phenomenon].
    Tolosa Vilella C; Simeón Aznar CP; Gabarró Julià L
    Med Clin (Barc); 2009 May; 132(18):712-8. PubMed ID: 19268319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Raynaud's phenomenon of the nipple associated with labetalol use.
    McGuinness N; Cording V
    J Hum Lact; 2013 Feb; 29(1):17-9. PubMed ID: 23212937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Secondary Raynaud's phenomenon].
    Röther E; Galle J; Peter HH
    Immun Infekt; 1993 Jun; 21(3):59-63. PubMed ID: 8392969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.